Papers: 10.1186/s40425-018-0464-1

https://doi.org/10.1186/s40425-018-0464-1

A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer

Cited by: 63
Author(s): Lucia D’Amico, Ulrike Menzel, Michael Prummer, Philipp Müller, Mélanie Buchi, Abhishek S. Kashyap, Ulrike Haessler, Alexander Yermanos, Rémy Gébleux, Manfred Briendl, Tamara Hell, Fabian I. Wolter, Roger R. Beerli, Iva Truxová, Radek Špíšek, Tatjana Vlajnic, Ulf Grawunder, Sai T. Reddy, Alfred Zippelius
Published: over 6 years ago

Software Mentions 4